Eyebright Medical Total Debt vs. Shares Outstanding

688050 Stock   91.28  2.78  3.14%   
Taking into consideration Eyebright Medical's profitability measurements, Eyebright Medical Technology may not be well positioned to generate adequate gross income at this time. It has a very high probability of underperforming in January. Profitability indicators assess Eyebright Medical's ability to earn profits and add value for shareholders.
For Eyebright Medical profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Eyebright Medical to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Eyebright Medical Technology utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Eyebright Medical's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Eyebright Medical Technology over time as well as its relative position and ranking within its peers.
  
Check out Trending Equities.
Please note, there is a significant difference between Eyebright Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Eyebright Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Eyebright Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Eyebright Medical Shares Outstanding vs. Total Debt Fundamental Analysis

Comparative valuation techniques use various fundamental indicators to help in determining Eyebright Medical's current stock value. Our valuation model uses many indicators to compare Eyebright Medical value to that of its competitors to determine the firm's financial worth.
Eyebright Medical Technology is the top company in total debt category among its peers. It also is number one stock in shares outstanding category among its peers creating about  1.61  of Shares Outstanding per Total Debt. As of December 1, 2024, Common Stock Shares Outstanding is expected to decline to about 106.7 M. Comparative valuation analysis is a catch-all model that can be used if you cannot value Eyebright Medical by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Eyebright Medical's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.

Eyebright Total Debt vs. Competition

Eyebright Medical Technology is the top company in total debt category among its peers. Total debt of Health Care industry is presently estimated at about 2.95 Billion. Eyebright Medical holds roughly 117.94 Million in total debt claiming about 4% of equities under Health Care industry.
Total debt  Revenue  Capitalization  Workforce  Valuation

Eyebright Shares Outstanding vs. Total Debt

Total Debt refers to the amount of long term interest-bearing liabilities that a company carries on its balance sheet. That may include bonds sold to the public, notes written to banks or capital leases. Typically, debt can help a company magnify its earnings, but the burden of interest and principal payments will eventually prevent the firm from borrow excessively.

Eyebright Medical

Total Debt

 = 

Bonds

+

Notes

 = 
117.94 M
In most industries, total debt may also include the current portion of long-term debt. Since debt terms vary widely from one company to another, simply comparing outstanding debt obligations between different companies may not be adequate. It is usually meant to compare total debt amounts between companies that operate within the same sector.
Outstanding Shares are shares of common stock of a public company that were purchased by investors after they were authorized and issued by the company to the public. Outstanding Shares are typically reported on fully diluted basis, including exotic instruments such as options, or convertibles bonds.

Eyebright Medical

Shares Outstanding

 = 

Public Shares

-

Repurchased

 = 
189.54 M
Outstanding shares that are stated on company Balance Sheet are used when calculating many important valuation and performance indicators including Return on Equity, Market Cap, EPS and many others.

Eyebright Shares Outstanding Comparison

Eyebright Medical is currently under evaluation in shares outstanding category among its peers.

Eyebright Medical Profitability Projections

The most important aspect of a successful company is its ability to generate a profit. For investors in Eyebright Medical, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Eyebright Medical will eventually generate negative long term returns. The profitability progress is the general direction of Eyebright Medical's change in net profit over the period of time. It can combine multiple indicators of Eyebright Medical, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
Last ReportedProjected for Next Year
Operating Income328.3 M344.7 M
Income Before Tax327.7 M344.1 M
Total Other Income Expense Net5.5 M5.8 M
Net Income304.4 M319.7 M
Income Tax Expense42.4 M44.5 M
Net Interest Income-3.5 M-3.4 M
Interest Income6.4 M6.2 M
Net Income From Continuing Ops286.1 M185.4 M

Eyebright Profitability Driver Comparison

Profitability drivers are factors that can directly affect your investment outlook on Eyebright Medical. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Eyebright Medical position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Eyebright Medical's important profitability drivers and their relationship over time.

Use Eyebright Medical in pair-trading

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Eyebright Medical position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Eyebright Medical will appreciate offsetting losses from the drop in the long position's value.

Eyebright Medical Pair Trading

Eyebright Medical Technology Pair Trading Analysis

The ability to find closely correlated positions to Eyebright Medical could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Eyebright Medical when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Eyebright Medical - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Eyebright Medical Technology to buy it.
The correlation of Eyebright Medical is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Eyebright Medical moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Eyebright Medical moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Eyebright Medical can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Use Investing Themes to Complement your Eyebright Medical position

In addition to having Eyebright Medical in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Education Thematic Idea Now

Education
Education Theme
Companies involved in apprenticeship, education, tutoring, schooling, online universities, and other learning services. The Education theme has 46 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Education Theme or any other thematic opportunities.
View All  Next Launch

Other Information on Investing in Eyebright Stock

To fully project Eyebright Medical's future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of Eyebright Medical at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include Eyebright Medical's income statement, its balance sheet, and the statement of cash flows.
Potential Eyebright Medical investors and stakeholders can use historical trends found within financial statements to determine how well the company is positioned for the future. Although Eyebright Medical investors may work on each financial statement separately, they are all related. The changes in Eyebright Medical's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Eyebright Medical's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet but not equivalent to net income shown on the income statement. Please read more on our technical analysis and fundamental analysis pages.